文献速递临床试验与 GCP

腹腔镜袖状胃切除与Roux-en-Y胃旁路术对病态肥胖患者减重的效果:SM-BOSS随机临床试验

Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial.
PubMed 文献 · JAMA · 2018-01-01

SM-BOSS多中心随机试验纳入217例病态肥胖患者,随机接受腹腔镜袖状胃切除(n=107)或腹腔镜Roux-en-Y胃旁路术(n=110),随访5年。胃旁路术组胃食管反流缓解率更高(60.4% vs 25.0%),袖状胃切除组反流加重更常见(31.8% vs 6.3%)。

要点

  • 胃食管反流缓解:胃旁路术60.4% vs 袖状胃切除25.0%。
  • 反流加重:袖状胃切除31.8% vs 胃旁路术6.3%。

核心结论

  • 在病态肥胖患者中,腹腔镜袖状胃切除与腹腔镜Roux-en-Y胃旁路术后5年 excess BMI loss 无显著差异。

研究设计与样本

  • SM-BOSS为两组随机试验,2007年1月至2011年11月在4家瑞士减重中心开展,末次随访2017年3月。
  • 从3971例接受减重手术评估的病态肥胖患者中入组217例,随机分配至袖状胃切除(n=107)或Roux-en-Y胃旁路术(n=110),随访5年。
  • 217例患者平均年龄45.5岁,女性占72%,平均BMI 43.9;205例(94.5%)完成试验。

主要发现

  • 胃食管反流缓解:胃旁路术60.4% vs 袖状胃切除25.0%。
  • 胃食管反流加重(症状增多或治疗升级):袖状胃切除31.8% vs 胃旁路术6.3%。
  • 再手术或干预患者数:袖状胃切除16/101(15.8%) vs 胃旁路术23/104(22.1%)。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Sleeve gastrectomy is increasingly used in the treatment of morbid obesity, but its long-term outcome vs the standard Roux-en-Y gastric bypass procedure is unknown. OBJECTIVE: To determine whether there are differences between sleeve gastrectomy and Roux-en-Y gastric bypass in terms of weight loss, changes in comorbidities, increase in quality of life, and adverse events. DESIGN, SETTING, AND PARTICIPANTS: The Swiss Multicenter Bypass or Sleeve Study (SM-BOSS), a 2-group randomized trial, was conducted from January 2007 until November 2011 (last follow-up in March 2017). Of 3971 morbidly obese patients evaluated for bariatric surgery at 4 Swiss bariatric centers, 217 patients were enrolled and randomly assigned to sleeve gastrectomy or Roux-en-Y gastric bypass with a 5-year follow-up period. INTERVENTIONS: Patients were randomly assigned to undergo laparoscopic sleeve gastrectomy (n = 107) or laparoscopic Roux-en-Y gastric bypass (n = 110). MAIN OUTCOMES AND MEASURES: The primary end point was weight loss, expressed as percentage excess body mass index (BMI) loss. Exploratory end points were changes in comorbidities and adverse events. RESULTS: Among the 217 patients (mean age, 45.5 years; 72% women; mean BMI, 43.9) 205 (94.5%) completed the trial. Excess BMI loss was not significantly different at 5 years: for sleeve gastrectomy, 61.1%, vs Roux-en-Y gastric bypass, 68.3% (absolute difference, -7.18%; 95% CI, -14.30% to -0.06%; P = .22 after adjustment for multiple comparisons). Gastric reflux remission was observed more frequently after Roux-en-Y gastric bypass (60.4%) than after sleeve gastrectomy (25.0%). Gastric reflux worsened (more symptoms or increase in therapy) more often after sleeve gastrectomy (31.8%) than after Roux-en-Y gastric bypass (6.3%). The number of patients with reoperations or interventions was 16/101 (15.8%) after sleeve gastrectomy and 23/104 (22.1%) after Roux-en-Y gastric bypass. CONCLUSIONS AND RELEVANCE: Among patients with morbid obesity, there was no significant difference in excess BMI loss between laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass at 5 years of follow-up after surgery. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00356213.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial. JAMA. 2018. PMID: 29340679. doi:10.1001/jama.2017.20897

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。